A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

The new vaccine is "personalized," meaning it is designed to train the patient's immune system to recognize and eliminate any remaining cells of that person's cancer.

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...

This Research Topic explores multiple facets of antigen presentation in cancer, ranging from pathways that regulate dendritic cell (DC) functions to innovative strategies for enhancing antigen ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could ...

Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...